Freedom SOLO Stentless Heart Valve Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 251 participants.

Also called NCT01115907

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 251 participants (enrolled count) (from the registry)
Sponsor
Sorin Group USA, Inc. (from the registry)
Registry
  • NCT NCT01115907
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01115907. Allocation not applicable; no masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2014-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Freedom SOLO Stentless Heart Valve Study
Acronym
SOLO
Condition
Aortic Stenosis
Condition
Aortic Insufficiency
Intervention (Device)
Freedom SOLO Stentless Heart Valve
Lead sponsor
Sorin Group USA, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01115907
Content hash
7c81833b12a0bdc6b6f8d9cc224e8cae6411a4acb1ef0b5059fbff168b0e1e60